Provided by the National Library of Medicine, National Institutes of Health
Treasure Island (FL): StatPearls Publishing; January 2025 onwards
The Authors
By Evan Los and Andrew S. Wilt
Writers
Affiliations
Last Updated: June 26, 2023
Evan Los and Andrew S. Wilt are accomplished writers with a passion for storytelling and a knack for captivating their readers. Both authors have a strong background in journalism and have written for various publications.
Andrew S. Wilt is known for his in-depth analysis of current events and social issues, while Evan Los is praised for his engaging writing style and unique perspective on everyday topics.
Together, they have collaborated on numerous projects, combining their complementary skills to produce compelling and thought-provoking content.
Overview of Type 1 Diabetes
Type 1 diabetes is a condition where the immune system destroys pancreatic beta cells, leading to insufficient insulin production and high blood sugar levels. Managing this chronic disease involves insulin replacement and patient commitment. Treatment focuses on reducing hyperglycemia while minimizing the risk of low blood sugar. Effective glucose control is influenced by various factors, with education playing a vital role in patients’ lives.
Emphasis on Improving Interprofessional Collaboration for Children with Type 1 Diabetes
Interprofessional collaboration is essential in providing comprehensive care for children with type 1 diabetes. This approach involves healthcare professionals from different disciplines working together to address all aspects of the child’s health and well-being.
Pediatric endocrinologists, diabetes educators, dietitians, nurses, and mental health professionals should collaborate closely to create individualized treatment plans, monitor the child’s progress, and provide ongoing support. Communication and coordination among team members are crucial to ensure seamless care delivery and achieve optimal outcomes for the child.
By fostering strong interprofessional relationships and promoting effective teamwork, healthcare providers can enhance the quality of care for children with type 1 diabetes, helping them lead healthy and fulfilling lives.
Understanding Type 1 Diabetes
Type 1 diabetes is an autoimmune disorder characterized by inadequate insulin production and elevated blood sugar levels. The condition necessitates intensive effort and insulin therapy to manage hyperglycemia while preventing hypoglycemia. Patient education is essential to navigate daily life with the disease.
People with type 1 diabetes need to closely monitor their blood sugar levels throughout the day and adjust their insulin doses accordingly. They must also carefully balance their food intake, exercise, and insulin to maintain stable blood sugar levels. Additionally, regular visits to healthcare providers, including endocrinologists and diabetes educators, are crucial for managing the disease effectively.
Genetic and Environmental Factors in Type 1 Diabetes
Both genetic predisposition and environmental triggers contribute to the immune-mediated destruction of beta cells, resulting in insulin dependence and high blood sugar. The disease progresses through preclinical stages before manifesting as symptomatic diabetes, prompting research into delaying its onset.
Recent studies have shown that certain genes, such as HLA-DQ and INS, play a significant role in predisposing individuals to type 1 diabetes. However, environmental factors, such as viral infections or early exposure to cow’s milk, can also trigger the autoimmune response that leads to beta cell destruction.
Understanding the interplay between genetic and environmental factors is crucial for developing effective prevention and treatment strategies for type 1 diabetes. By identifying individuals at high risk and implementing targeted interventions, researchers hope to delay or even prevent the onset of the disease in susceptible individuals.
Epidemiology of Type 1 Diabetes
Type 1 diabetes can manifest at any age, with peaks around 5-7 years old and during puberty. Incidence varies geographically and ethnically, with a rising prevalence in the United States. Genetic factors play a significant role in the development of the disease.
Complications of Insufficient Insulin in Type 1 Diabetes
Inadequate insulin levels lead to hyperglycemia, ketoacidosis, acidosis, and dehydration. Timely diagnosis is critical to prevent severe complications. Long-term effects of high blood sugar necessitate meticulous glucose management.
It is important for individuals with type 1 diabetes to regularly monitor their blood sugar levels and adhere to their insulin regimen to prevent complications. Uncontrolled high blood sugar over time can lead to damage to the eyes, kidneys, nerves, and heart. Additionally, it can increase the risk of developing long-term complications such as cardiovascular disease and stroke.
Proper insulin management, along with a healthy diet and regular physical activity, is key to controlling blood sugar levels and reducing the risk of complications in individuals with type 1 diabetes. Education and support from healthcare providers are essential in helping individuals manage their condition effectively and maintain their overall health.
Management of Ketosis and Diabetic Ketoacidosis in Type 1 Diabetes
Low insulin levels or inadequate oral intake can trigger ketosis and ketoacidosis. Prompt treatment is essential to prevent severe acidosis and hospitalization, although admissions for diabetic ketoacidosis are relatively low.
Symptoms and Follow-Up in Children with Type 1 Diabetes
Children with type 1 diabetes may exhibit symptoms like frequent urination, excessive thirst, weight loss, and ketoacidosis. Regular monitoring and follow-up visits are crucial to manage changes in diabetes status and life circumstances.
- Regular exercise is important for managing blood glucose levels in diabetic children. It can help increase insulin sensitivity and overall health.
- Education on recognizing and treating hypoglycemia is crucial for both parents and children to prevent dangerous situations.
- Support groups and counseling can be beneficial for both children and families dealing with the challenges of diabetes management.
- Technology such as continuous glucose monitors and insulin pumps can greatly assist in monitoring and controlling blood sugar levels more effectively.
- A balanced diet rich in fruits, vegetables, whole grains, and lean proteins is essential for overall health and diabetes management in children.
Overall, a multidisciplinary approach with regular monitoring, education, support, and personalized treatment plans is key to effectively managing diabetes in children and improving their quality of life.
Enhancing Diabetes Care for Children
For optimal care, children need access to a specialized healthcare team consisting of a diabetologist, nurse educator, dietitian, and additional support from psychologists and social workers as required. Tailored education programs are crucial for effective diabetes management, along with increased blood glucose monitoring and parental involvement. Collaboration with schools, daycares, and community programs can provide essential support for families during diabetes management.
Progress in Insulin Therapy in Hannover
In Hannover, advancements in insulin therapy, education, self-monitoring, and diabetes teams have enhanced glycemic control with multiple daily injections and insulin pumps. Setting clear targets and adopting intensive insulin regimens are critical for children with diabetes. Proper distribution of insulin throughout the day is key to achieving near-normal blood sugar levels. International studies demonstrate improved HbA1c outcomes, underscoring the importance of treatment goals in managing diabetes.
While inhaled insulin and incretin-based therapies show promise, research on islet and stem cell transplants is ongoing. The long-term benefits and ramifications of these interventions are still being explored but hold potential for improving outcomes in diabetic children.
Illustration of Insulin Therapy Advancements
Figure 4: Depicts the progression to intensified insulin therapy at a hospital in Hannover, Germany, and the subsequent improvement in glycemic control over the years.
Key Definitions
- CSII – Continuous Subcutaneous Insulin Infusion
- DCCT – Diabetes Control and Complications Trial
- EDIC – Epidemiology of Diabetes Interventions and Complications
- GLP-1 – Glucagon-Like Peptide 1
- MDI – Multiple Daily Injections
- NPH – Neutral Protamine Hagedorn
Authors’ Disclosure
Authors have no conflicts of interest related to the content of this manuscript, despite prior associations and support from pharmaceutical companies in the diabetes sector.
References
- The DCCT Research Group publication on intensive diabetes treatment outcomes in adolescents.
- DCCT/EDIC Research Group study on the benefits of diabetes therapy during adolescence.
- Danne T, Weber B, Hartmann R. Long-term glycemic control and background retinopathy frequency in adolescents.
- Dahl-Jorgensen K, Larsen JR, Hanssen KF. Atherosclerosis in childhood and adolescent type 1 diabetes.
- ISPAD and NICE guidelines for managing diabetes in children and adolescents.
- Mortensen HB, Hougaard P. Metabolic control in children and adolescents with IDDM.
- Silverstein J, Klingensmith G, Copeland K. Care of children and adolescents with type 1 diabetes.
- Dorchy H. Dietary management for children and adolescents with diabetes mellitus.
- Phillip M, Battelino T, Rodriguez H. Use of insulin pump therapy in the pediatric age group.
2. A study was conducted on 377 children and adolescents with type 1 diabetes from 10 different countries to investigate the use of continuous subcutaneous insulin infusion. The results were published in Pediatr Diabetes in 2005.
3. The benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes were examined by a research team in a follow-up report published in Pediatrics in 2004.
4. A study conducted in 2000 focused on the rapid appearance and onset of action of insulin aspart in pediatric subjects with type 1 diabetes, as published in Eur J Pediatr.
5. The pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes were investigated in a study published in Diabetes Care in 2005.
6. Both insulin sensitivity and clearance in children and young adults with type 1 diabetes were found to vary with growth hormone concentrations and age in a study published in Diabetologia in 2000.
7. A comparison between postprandial and pre-prandial administration of insulin aspart in children and adolescents with type 1 diabetes was conducted and discussed in Diabetes Care in 2003.
8. Parental preference for prandial insulin aspart was compared to preprandial human insulin in a study involving preschool children with type 1 diabetes, as reported in a publication in Pediatr Diabetes in 2007.
9. Insulin detemir was found to have a consistent pharmacokinetic profile across different age groups in children, adolescents, and adults with type 1 diabetes in a study published in Diabetes Care in 2003.
10. Flexible insulin therapy with glargine insulin was found to improve glycemic control and reduce severe hypoglycemia in preschool-aged children with type 1 diabetes in a study published in Pediatrics in 2005.
11. The use of insulin glargine and neutral protamine Hagedorn insulin was associated with reduced hypoglycemic episodes and improved glycemic control in children with type 1 diabetes, as reported in J Pediatr in 2003.
12. A comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes was conducted and published in J Pediatr Endocrinol Metab in 2002.
13. Insulin detemir was found to offer benefits over NPH insulin in children and adolescents with type 1 diabetes, including lower fasting plasma glucose and reduced risk of nocturnal hypoglycemia, as reported in Diabet Med in 2005.
14. The efficacy and safety of bedtime insulin detemir versus insulin semilente in children, adolescents, and young adults with type 1 diabetes was examined in a randomized study published in Pediatr Diabetes in 2006.
15. A study on mobile diabetes education and care interventions for children and young people with type 1 diabetes in rural areas of northern Germany was published in Diabet Med in 2006.
16. Social support and personal models of diabetes were found to be predictors of self-care and well-being in adolescents with diabetes in a longitudinal study published in J Pediatr Psychol in 2000.